DK475389D0 - Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet - Google Patents

Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet

Info

Publication number
DK475389D0
DK475389D0 DK475389A DK475389A DK475389D0 DK 475389 D0 DK475389 D0 DK 475389D0 DK 475389 A DK475389 A DK 475389A DK 475389 A DK475389 A DK 475389A DK 475389 D0 DK475389 D0 DK 475389D0
Authority
DK
Denmark
Prior art keywords
monoclonal antibodies
reducing heterogeneity
heterogeneity
reducing
monoclonal
Prior art date
Application number
DK475389A
Other languages
English (en)
Other versions
DK475389A (da
Inventor
Richard Mark Bartholomew
Thomas Charles Furman
Rodney Alan Jue
James Patrick Mcdonough
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/364,056 external-priority patent/US5126250A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK475389D0 publication Critical patent/DK475389D0/da
Publication of DK475389A publication Critical patent/DK475389A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK475389A 1988-09-28 1989-09-27 Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet DK475389A (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25078788A 1988-09-28 1988-09-28
US25078888A 1988-09-28 1988-09-28
US25078688A 1988-09-28 1988-09-28
US07/364,056 US5126250A (en) 1988-09-28 1989-06-09 Method for the reduction of heterogeneity of monoclonal antibodies
CA000613379A CA1332367C (en) 1988-09-28 1989-09-26 Method for the reduction of heterogeneity of monoclonal antibodies

Publications (2)

Publication Number Publication Date
DK475389D0 true DK475389D0 (da) 1989-09-27
DK475389A DK475389A (da) 1990-03-29

Family

ID=27508376

Family Applications (1)

Application Number Title Priority Date Filing Date
DK475389A DK475389A (da) 1988-09-28 1989-09-27 Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet

Country Status (17)

Country Link
EP (1) EP0361902B1 (da)
JP (1) JP2925181B2 (da)
CN (1) CN1041392A (da)
AR (1) AR242986A1 (da)
AT (1) ATE101876T1 (da)
AU (1) AU615576B2 (da)
BG (1) BG60017B2 (da)
CA (1) CA1332367C (da)
DE (1) DE68913251T2 (da)
DK (1) DK475389A (da)
ES (1) ES2049332T3 (da)
IE (1) IE63562B1 (da)
IL (1) IL91778A (da)
MX (1) MX170441B (da)
NZ (1) NZ230786A (da)
PL (1) PL162260B1 (da)
RO (1) RO105652B1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2006381B1 (en) 2006-03-31 2016-02-03 Chugai Seiyaku Kabushiki Kaisha Method for controlling blood pharmacokinetics of antibodies
EP1878747A1 (en) 2006-07-11 2008-01-16 greenovation Biotech GmbH Glyco-engineered antibodies
EP2031064A1 (de) * 2007-08-29 2009-03-04 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Steigerung von Proteintitern
SG193868A1 (en) 2007-09-26 2013-10-30 Chugai Pharmaceutical Co Ltd Modified antibody constant region
PL2202245T3 (pl) 2007-09-26 2017-02-28 Chugai Seiyaku Kabushiki Kaisha Sposób modyfikowania punktu izoelektrycznego przeciwciała poprzez podstawienie aminokwasu w cdr
ES2563483T3 (es) 2008-04-11 2016-03-15 Chugai Seiyaku Kabushiki Kaisha Molécula de unión a antígeno capaz de unirse repetidamente a dos o más moléculas de antígeno
TWI440469B (zh) * 2008-09-26 2014-06-11 Chugai Pharmaceutical Co Ltd Improved antibody molecules
JP5717624B2 (ja) 2009-03-19 2015-05-13 中外製薬株式会社 抗体定常領域改変体
EP2826789A1 (en) 2009-03-19 2015-01-21 Chugai Seiyaku Kabushiki Kaisha Antibody constant region variant
US20140234340A1 (en) 2010-11-30 2014-08-21 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
SG191371A1 (en) * 2010-12-28 2013-08-30 Chugai Pharmaceutical Co Ltd Animal cell culturing method
RU2662991C2 (ru) * 2013-03-12 2018-07-31 Биокон Лтд. Слитые иммуномодулирующие белки и способы их получения
US10782290B2 (en) 2013-06-11 2020-09-22 National Center Of Neurology And Psychiatry Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy
AU2016224409B2 (en) 2015-02-27 2021-01-28 Chugai Seiyaku Kabushiki Kaisha Composition for treating IL-6-related diseases
PL3299810T3 (pl) 2015-05-19 2021-12-13 National Center Of Neurology And Psychiatry Sposób określania zastosowania nowej terapii u pacjentów ze stwardnieniem rozsianym (sm)
ES2876416T3 (es) * 2016-10-17 2021-11-12 Enzene Biosciences Ltd Procedimiento continuo para reducir la heterogeneidad de proteína terapéutica
EP3620531A4 (en) 2017-05-02 2021-03-17 National Center of Neurology and Psychiatry METHOD OF PREDICTION AND EVALUATION OF THERAPEUTIC EFFECT IN DISEASES RELATING TO IL-6 AND NEUTROPHILS
KR20200074160A (ko) 2017-10-20 2020-06-24 가꼬우호우징 효고 이카다이가쿠 항il-6 수용체 항체를 함유하는 수술 후의 유착을 억제하기 위한 의약 조성물

Also Published As

Publication number Publication date
AU4234389A (en) 1990-04-05
MX170441B (es) 1993-08-23
EP0361902A3 (en) 1990-08-16
BG60017B2 (en) 1993-06-30
CA1332367C (en) 1994-10-11
CN1041392A (zh) 1990-04-18
DK475389A (da) 1990-03-29
JPH02163096A (ja) 1990-06-22
IL91778A (en) 1994-10-07
IE893094L (en) 1990-03-28
AR242986A1 (es) 1993-06-30
DE68913251T2 (de) 1994-06-23
EP0361902A2 (en) 1990-04-04
ATE101876T1 (de) 1994-03-15
ES2049332T3 (es) 1994-04-16
NZ230786A (en) 1991-11-26
EP0361902B1 (en) 1994-02-23
AU615576B2 (en) 1991-10-03
RO105652B1 (ro) 1992-11-30
PL162260B1 (pl) 1993-09-30
DE68913251D1 (de) 1994-03-31
IE63562B1 (en) 1995-05-17
JP2925181B2 (ja) 1999-07-28

Similar Documents

Publication Publication Date Title
DK475389D0 (da) Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet
DK65185A (da) Fremgangsmaade til fremstilling af antistof
DK98584A (da) Fremgangsmaade til detektering af aendret dna
DK610587A (da) Analysemetode og -saet for antistof til hepatitis b-kerneantigen
DK188185A (da) Monoklonalt antistof
DK14589A (da) Fremgangsmaade til fremstilling af 1-alkyl-5-nitroimidazoler
DK319685D0 (da) Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne
DK409388D0 (da) Fremgangsmaade til reduktion af ketoner
DK388787A (da) Fremgangsmaade til fremstilling af interferon
DK717888D0 (da) Monoklonale antistoffer
DK437087D0 (da) Monoklont antistof til bestemmelse af humant glycoalbumin
DK144485D0 (da) Monoklonale antistoffer
DK355584A (da) Fremgangsmaade til fremstilling af 3-exomethylen-cephalosporiner
DK147885D0 (da) Fremgangsmaade til fremstilling af glycosidbindingrelateret antigen
DK276185D0 (da) Monoklonale antistoffer,fremgangsmaade til fremstilling af disse samt deres diagnostiske anvendelse
DK0401657T3 (da) Fremgangsmåde til C-terminal modificering af proteiner
DK413389D0 (da) Monoklonale antistoffer
DK161570C (da) Fremgangsmaade og apparat til korrugering af metalroer
DK338889A (da) Fremgangsmaade til bestemmelse af antistoffer
DK240286A (da) Monoklonale antistoffer
DK143389A (da) Fremgangsmaade til fremstilling af 20-deoxotylosin
DK49585D0 (da) Fremgangsmaade til paavirkning af laeskehastigheden for braendt kalk og anvendelse af fremgangsmaaden
DK338584D0 (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalaninalkylestere
ZA897324B (en) Method for the reduction of heterogeneity of monoclonal antibodies
DK156388C (da) Fremgangsmaade til fremstilling af nitroalkaner

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment